Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

被引:0
|
作者
Serge Rozenberg
Jean-Jacques Body
Olivier Bruyère
Pierre Bergmann
Maria Luisa Brandi
Cyrus Cooper
Jean-Pierre Devogelaer
Evelien Gielen
Stefan Goemaere
Jean-Marc Kaufman
René Rizzoli
Jean-Yves Reginster
机构
[1] University of Liège,Department of Public Health, Epidemiology and Health Economics
[2] Université Libre de Bruxelles,Department of Gynaecology
[3] Université Libre de Bruxelles,Obstetrics
[4] Université Libre de Bruxelles,Department of Medicine, CHU Brugmann
[5] University of Florence,Department of Radioisotopes, CHU Brugmann
[6] University of Southampton,Metabolic Bone Unit, Department of Internal Medicine
[7] University of Oxford,MRC Lifecourse Epidemiology Unit
[8] Université Catholique de Louvain,Department of Rheumatology, Saint Luc University Hospital
[9] Katholiek Universiteit Leuven,Gerontology and Geriatrics Section, Department of Experimental Medicine
[10] State University of Ghent,Department of Rheumatology and Endocrinology
[11] State University of Ghent,Department of Endocrinology
[12] Geneva University Hospitals and Faculty of Medicine,Division of Bones Diseases
来源
关键词
Dairy products; Cardiovascular disease; Osteoporosis; Arthritis; Weight management; Lactose intolerance;
D O I
暂无
中图分类号
学科分类号
摘要
Dairy products provide a package of essential nutrients that is difficult to obtain in low-dairy or dairy-free diets, and for many people it is not possible to achieve recommended daily calcium intakes with a dairy-free diet. Despite the established benefits for bone health, some people avoid dairy in their diet due to beliefs that dairy may be detrimental to health, especially in those with weight management issues, lactose intolerance, osteoarthritis, rheumatoid arthritis, or trying to avoid cardiovascular disease. This review provides information for health professionals to enable them to help their patients make informed decisions about consuming dairy products as part of a balanced diet. There may be a weak association between dairy consumption and a possible small weight reduction, with decreases in fat mass and waist circumference and increases in lean body mass. Lactose intolerant individuals may not need to completely eliminate dairy products from their diet, as both yogurt and hard cheese are well tolerated. Among people with arthritis, there is no evidence for a benefit to avoid dairy consumption. Dairy products do not increase the risk of cardiovascular disease, particularly if low fat. Intake of up to three servings of dairy products per day appears to be safe and may confer a favourable benefit with regard to bone health.
引用
收藏
页码:1 / 17
页数:16
相关论文
共 50 条
  • [1] u Effects of Dairy Products Consumption on Health: Benefits and Beliefs-A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    Rozenberg, Serge
    Body, Jean-Jacques
    Bruyere, Olivier
    Bergmann, Pierre
    Brandi, Maria Luisa
    Cooper, Cyrus
    Devogelaer, Jean-Pierre
    Gielen, Evelien
    Goemaere, Stefan
    Kaufman, Jean-Marc
    Rizzoli, Rene
    Reginster, Jean-Yves
    CALCIFIED TISSUE INTERNATIONAL, 2016, 98 (01) : 1 - 17
  • [2] An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Bruyere, Olivier
    Honvo, Germain
    Veronese, Nicola
    Arden, Nigel K.
    Branco, Jaime
    Curtis, Elizabeth M.
    Al-Daghri, Nasser M.
    Herrero-Beaumont, Gabriel
    Martel-Pelletier, Johanne
    Pelletier, Jean-Pierre
    Rannou, Francois
    Rizzoli, Rene
    Roth, Roland
    Uebelhart, Daniel
    Cooper, Cyrus
    Reginster, Jean-Yves
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (03) : 337 - 350
  • [3] MANAGEMENT OF KNEE OSTEOARTHRITIS IN 2019: AN UPDATED ALGORITHM FROM THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES (ESCEO)
    Reginster, J. -Y.
    Bruyere, Olivier
    Honvo, Germain
    Veronese, Nicola
    Arden, Nigel K.
    Branco, Jaime
    Curtis, Elizabeth
    Al-Daghri, Nasser M.
    Herrero-Beaumont, Gabriel
    Hochberg, Marc C.
    Martel-Pelletier, Johanne
    Pelletier, Jean-Pierre
    Rannou, Francois
    Rizzoli, Rene
    Roth, Roland
    Uebelhart, Daniel
    Cooper, Cyrus
    Reginster, Jean-Yves
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S158 - S159
  • [4] Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)
    Biver, Emmanuel
    Berenbaum, Francis
    Valdes, Ana M.
    de Carvalho, Islene Araujo
    Bindels, Laure B.
    Brand, Maria Luisa
    Calder, Philip C.
    Castronovo, Vincenzo
    Cavalier, Etienne
    Cherubini, Antonio
    Cooper, Cyrus
    Dennison, Elaine
    Franceschi, Claudio
    Fuggle, Nicholas
    Laslop, Andrea
    Miossec, Pierre
    Thomas, Thierry
    Tuzun, Sansin
    Veronese, Nicola
    Vlaskovska, Mila
    Reginster, Jean-Yves
    Rizzoli, Rene
    AGEING RESEARCH REVIEWS, 2019, 55
  • [5] Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation
    R. Rizzoli
    E. Biver
    J.-P. Bonjour
    V. Coxam
    D. Goltzman
    J. A. Kanis
    J. Lappe
    L. Rejnmark
    S. Sahni
    C. Weaver
    H. Weiler
    J.-Y. Reginster
    Osteoporosis International, 2018, 29 : 1933 - 1948
  • [6] Benefits and safety of dietary protein for bone health-an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation
    Rizzoli, R.
    Biver, E.
    Bonjour, J. -P.
    Coxam, V.
    Goltzman, D.
    Kanis, J. A.
    Lappe, J.
    Rejnmark, L.
    Sahni, S.
    Weaver, C.
    Weiler, H.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (09) : 1933 - 1948
  • [7] Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Reginster, Jean-Yves L.
    Arden, Nigel K.
    Haugen, Ida K.
    Rannou, Francois
    Cavalier, Etienne
    Bruyere, Olivier
    Branco, Jaime
    Chapurlat, Roland
    Basset, Sabine Collaud
    Al-Daghri, Nasser M.
    Dennison, Elaine M.
    Herrero-Beaumont, Gabriel
    Laslop, Andrea
    Leeb, Burkhard F.
    Maggi, Stefania
    Mkinsi, Ouafa
    Povzun, Anton S.
    Prieto-Alhambra, Daniel
    Thomas, Thierry
    Uebelhart, Daniel
    Veronese, Nicola
    Cooper, Cyrus
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (01) : 1 - 8
  • [8] Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Germain Honvo
    Raveendhara R. Bannuru
    Olivier Bruyère
    Francois Rannou
    Gabriel Herrero-Beaumont
    Daniel Uebelhart
    Cyrus Cooper
    Nigel Arden
    Philip G. Conaghan
    Jean-Yves Reginster
    Thierry Thomas
    Tim McAlindon
    Drugs & Aging, 2019, 36 : 145 - 159
  • [9] Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Honvo, Germain
    Bannuru, Raveendhara R.
    Bruyere, Olivier
    Rannou, Francois
    Herrero-Beaumont, Gabriel
    Uebelhart, Daniel
    Cooper, Cyrus
    Arden, Nigel
    Conaghan, Philip G.
    Reginster, Jean-Yves
    Thomas, Thierry
    McAlindon, Tim
    DRUGS & AGING, 2019, 36 (Suppl 1) : 145 - 159
  • [10] Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Olivier Bruyère
    Cyrus Cooper
    Nasser M. Al-Daghri
    Elaine M. Dennison
    René Rizzoli
    Jean-Yves Reginster
    Aging Clinical and Experimental Research, 2018, 30 : 111 - 117